Oric Pharmaceuticals, Inc. (ORIC)
13.17
-0.46
(-3.37%)
USD |
NASDAQ |
Oct 23, 16:00
13.16
-0.01
(-0.08%)
After-Hours: 20:00
Oric Pharmaceuticals EPS Diluted (Quarterly) : -0.3841 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3841 |
| March 31, 2026 | -0.3391 |
| December 31, 2025 | -0.2974 |
| September 30, 2025 | -0.3293 |
| June 30, 2025 | -0.4653 |
| March 31, 2025 | -0.4226 |
| December 31, 2024 | -0.5139 |
| September 30, 2024 | -0.49 |
| June 30, 2024 | -0.4544 |
| March 31, 2024 | -0.3714 |
| December 31, 2023 | -0.493 |
| September 30, 2023 | -0.4438 |
| June 30, 2023 | -0.5026 |
| March 31, 2023 | -0.531 |
| December 31, 2022 | -0.5188 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.6274 |
| June 30, 2022 | -0.5138 |
| March 31, 2022 | -0.5873 |
| December 31, 2021 | -0.5782 |
| September 30, 2021 | -0.4724 |
| June 30, 2021 | -0.5724 |
| March 31, 2021 | -0.4501 |
| December 31, 2020 | -0.8373 |
| September 30, 2020 | -0.8428 |
| June 30, 2020 | -0.5097 |
| March 31, 2020 | -0.2967 |
| December 31, 2019 | -0.2794 |
| September 30, 2019 | -0.219 |
| June 30, 2019 | -0.1995 |
| March 31, 2019 | -0.2012 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -41.49M |
| Total Expenses (Quarterly) | 41.49M |
| Enterprise Value | 1.103B |
| Earnings Yield | -10.25% |
| Normalized Earnings Yield | -10.25 |